Effect of co-administration of two different phosphodiesterase inhibitors and a β3-adrenoceptor agonist in an experimental model of detrusor overactivity-Reference-Cited by-同舟云学术

Effect of co-administration of two different phosphodiesterase inhibitors and a β3-adrenoceptor agonist in an experimental model of detrusor overactivity

Published:2018-08 Issue: Volume:833 Page:425-431
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Linhares Bruno Lima,Nascimento Nilberto Robson Falcão,Gonzaga-Silva Lúcio Flávio,Santos Cláudia Ferreira,Moraes Manoel Odorico,Marinho Lucas Bernardo,Silva Ana Patrícia Gonçalves,Fonteles Manassés Claudino,Reges Ricardo

Publisher

Elsevier BV

Subject

Pharmacology

Reference27 articles.

1. Muscarinic receptors: their distribution and function in body systems, and the implications for treating overactive bladder;Abrams;Br. J. Pharmacol.,2006

2. New developments in the management of overactive bladder: focus on mirabegron and onabotulinumtoxinA;Andersson;Ther. Clin. Risk Manag.,2013

3. Selective beta(3)-adrenoceptor agonists for the treatment of overactive bladder;Andersson;J. Urol.,2013

4. The effects of antimuscarinic treatments in overactive bladder: an update of systematic review and meta-analysis;Chapple;Eur. Urol.,2008

5. Treatment of obesity-associated overactive bladder by the phosphodiesterase type-4 inhibitor roflumilast;Ding;Int. Urol. Nephrol.,2017

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current and Emerging Pharmacological Targets and Treatments of Urinary Incontinence and Related Disorders;Pharmacological Reviews;2023-03-14

2. Efficient resolution of 3-aryloxy-1,2-propanediols using CLEA-YCJ01 with high enantioselectivity;RSC Advances;2019

3. Effect of co-administration of BRL-37344 and tadalafil on reduction of overactive bladder symptoms after induction of detrusor overactivity in mice;Acta Cirurgica Brasileira;2019